Latest News

30 Jun 2021
Congratulations! We have completed our recruitment target of 1587 randomization on 30 June...
Read more
04 May 2021
We have reached 1569 by March 2021!
Read more
01 Jan 2021
We have reached 1553 by December 2020!
Read more
26 Oct 2020
We have reached 1538 by September 2020!
Read more

What is ASCOLT?

ASCOLT is an international multi-centre randomized placebo controlled trial that aims to evaluate the benefit of 3 yrs of adjuvant aspirin in patients who have already completed standard therapy for colorectal cancer. It is an investigator initiated study partnership across institutions in Asia and Australia – to address an important clinical question.